NeuroOne Medical Technologies Corporation (NMTC)

Market Cap	45.49M
Revenue (ttm)	6.63M
Net Income (ttm)	-5.34M
Shares Out	50.00M
EPS (ttm)	-0.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	164,092
Open	0.8700
Previous Close	0.8650
Day's Range	0.8700 - 0.9120
52-Week Range	0.3954 - 1.3900
Beta	0.72
Analysts	Strong Buy
Price Target	2.23 (+145.11%)
Earnings Date	Aug 14, 2025

About NMTC

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, radio frequency and brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company also foc...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 17
• Stock Exchange: NASDAQ
• Ticker Symbol: NMTC
• Website: https://nmtc1.com

Financial Performance

In 2024, NMTC's revenue was $3.45 million, an increase of 1.33% compared to the previous year's $3.41 million. Losses were -$12.32 million, 3.87% more than in 2023.

Analyst Summary

According to 2 analysts, the average rating for NMTC stock is "Strong Buy." The 12-month stock price target is $2.23, which is an increase of 145.11% from the latest price.

Price Target

$2.23

(145.11% upside)

Analyst Consensus: Strong Buy